Invention Grant
- Patent Title: Synthetic cannabinoid compounds for treatment of epilepsy, substance addiction and Alzheimer's disease
-
Application No.: US17383119Application Date: 2021-07-22
-
Publication No.: US11629355B2Publication Date: 2023-04-18
- Inventor: Jonnie R. Williams
- Applicant: MyMD Pharmaceuticals, Inc.
- Applicant Address: US MD Baltimore
- Assignee: MyMD Pharmaceuticals, Inc.
- Current Assignee: MyMD Pharmaceuticals, Inc.
- Current Assignee Address: US MD Baltimore
- Agency: Banner & Witcoff, Ltd.
- Main IPC: A61K31/00
- IPC: A61K31/00 ; C12N15/82 ; A61K31/352 ; A61K36/185
Abstract:
Synthetic cannabinoid compounds for treatment of epilepsy, substance addiction, and Alzheimer's disease by administering to an individual in need thereof a pharmaceutical composition including a compound having the structure: or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.
Public/Granted literature
- US20210380998A1 Synthetic Cannabinoid Compounds for Treatment of Substance Addiction and Other Disorders Public/Granted day:2021-12-09
Information query
